idarubicin has been researched along with Nephrotic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albayram, S; Bariş, S; Celkan, T; Doğru, O; Kiliçaslan, I; Ozdemir, N; Ozdil, M; Sever, L; Topal, N | 1 |
| McKenna, KE; Morris, TC; Ramadan, KM | 1 |
2 other study(ies) available for idarubicin and Nephrotic Syndrome
| Article | Year |
|---|---|
Acute promyelocytic leukemia treated with idarubicin complicated by focal segmental glomerulosclerosis.
Topics: Antibiotics, Antineoplastic; Child; Glomerulosclerosis, Focal Segmental; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Nephrotic Syndrome; Thrombosis | 2010 |
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Clarithromycin; Dexamethasone; Diphosphonates; Glomerulonephritis; Humans; Idarubicin; Imidazoles; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Pamidronate; Protein Synthesis Inhibitors; Pyrazines; Skin Neoplasms; Thalidomide; Zoledronic Acid | 2006 |